Brief: Chiome Bioscience signs license agreement related to antibody LIV-1205 for cancer treatment
27/09/2017 07:41
Sept 27 (Reuters) - Chiome Bioscience Inc 4583.T
* Says it signed license agreement with ADC Therapeutics SA,
regarding development, manufacture and sale of Antibody Drug
Conjugate of antibody LIV-1205 for cancer treatment
* Says it will receive upfront payment from ADC Therapeutics
SA
Source text in Japanese:https://goo.gl/oCUzd9
Further company coverage: 4583.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))